Pathways in cancer such as the phosphoinositide 3-kinases (PI3K)–Akt signaling pathway, hippo signaling pathway, proteoglycans in cancer, and other signaling pathways (Figures 5B–E) were significantly enriched in high-risk groups, which may partly explain the reason for poor prognosis in high-risk group patients. Here, AKT1 is linked to cancer.